JPH067161A - New endoglycoceramidase - Google Patents

New endoglycoceramidase

Info

Publication number
JPH067161A
JPH067161A JP4082768A JP8276892A JPH067161A JP H067161 A JPH067161 A JP H067161A JP 4082768 A JP4082768 A JP 4082768A JP 8276892 A JP8276892 A JP 8276892A JP H067161 A JPH067161 A JP H067161A
Authority
JP
Japan
Prior art keywords
enzyme
ceramide
activity
optimum
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4082768A
Other languages
Japanese (ja)
Other versions
JP3191170B2 (en
Inventor
Yasutaka Tawara
康孝 田原
Kiyoshi Morikawa
清志 森川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Priority to JP08276892A priority Critical patent/JP3191170B2/en
Publication of JPH067161A publication Critical patent/JPH067161A/en
Application granted granted Critical
Publication of JP3191170B2 publication Critical patent/JP3191170B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

PURPOSE:To enable ready analysis of a sugar chain structure of a glycolipid by using an enzyme capable of excellently acting on a sphingogllycolipid, especially a globoside-based one and also on a cerebroside composed of a monosaccharide bonded to a ceramide. CONSTITUTION:Endoglycocermidase (an enzyme) exhibits an activity against a sphingoglycolipid and can hydrolyze the sugar-ceramide bond through the activity so as to produce an oligosaccharide or a monosaccharide and a ceramide. This enzyme exhibits an activity also on a ganglioside-, globoside- and lactoside-based sphingoglycoside and on a cerebroside but can not exhibit an activity against a sulfatide. The optimum pH is 6 to 7 and the stable pH range is 6 to 9. The optimum temperature is 40 to 44 deg.C and the thermal stability is <=40 deg.C. This enzyme is inhibited by Hg<2+>, Zn<2+> and Ag<+> and activated by Ba<2+> and Mg<2+>. The enzyme can be obtained, e.g. by culturing No. 363-2-1 strain (FERM-P-12793), i.e., a Gram-positive short bacillus separated from the sheath of a bamboo shoot produced in Shizuoka prefecture, Japan and subsequently collecting from the cultured material.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は基質特異性の広い新規な
エンドクリコセラミダーゼに関するものである。このよ
うな酵素は、近年、生体内での重要性が注目されている
糖脂質の構造や機能を解明する上で有用である。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel endocrycoceramidase having a wide substrate specificity. Such an enzyme is useful for elucidating the structure and function of glycolipids, which have recently attracted attention in vivo importance.

【0002】[0002]

【従来の技術】従来、スフィンゴ糖脂質に作用してオリ
ゴ糖とセラミドを生成する微生物由来のエンドグリコセ
ラミダーゼとしては、ロドコッカス属に属する微生物が
生産する酵素(特開昭62−122587号公報参照)
とコリネバクテリウム属に属する微生物が生産する酵素
(生化学,第63巻,第8号,第796頁(1991
年)参照)が知られている。
2. Description of the Related Art Conventionally, as an endoglycoceramidase derived from a microorganism which acts on a glycosphingolipid to produce an oligosaccharide and ceramide, an enzyme produced by a microorganism belonging to the genus Rhodococcus (see JP-A-62-122587)
And enzymes produced by microorganisms belonging to the genus Corynebacterium (Biochemistry, 63, No. 8, p. 796 (1991)
Year))) is known.

【0003】前者には、オリゴ糖鎖中のグルコースが直
接セラミドと結合しているスフィンゴ糖脂質の、グルコ
ースとセラミドとの結合を特異的に切断してオリゴ糖を
生成するがグルコースのような単糖とセラミドとが結合
したセレブロシドは分解しない酵素(分子量 約23万
(ゲルロ過),至適pH 6.0,安定pH 5〜9,
作用最適温度 37℃)及びオリゴ糖鎖中のガラクトー
スが直接セラミドと結合しているスフィンゴ糖脂質の、
ガラクトースとセラミドとの結合を特異的に切断してオ
リゴ糖を生成するがガラクトースのような単糖とセラミ
ドとが結合したセレブロシドは分解しない酵素(分子量
約16万(ゲルロ過),至適pH 5.0,安定pH
5〜9,作用最適温度 37℃)が含まれる。
In the former, a glycosphingolipid, in which glucose in an oligosaccharide chain is directly bound to ceramide, specifically cleaves the bond between glucose and ceramide to form an oligosaccharide. An enzyme that does not decompose cerebroside, which is a combination of sugar and ceramide (molecular weight: about 230,000 (gel filtration), optimum pH 6.0, stable pH 5-9,
The optimum temperature of action 37 ° C) and the glycosphingolipid in which galactose in the oligosaccharide chain is directly bound to ceramide,
An enzyme that specifically cleaves the bond between galactose and ceramide to form an oligosaccharide, but does not decompose cerebroside in which a monosaccharide such as galactose and ceramide are combined (molecular weight: about 160,000 (gel filtration), optimum pH 5 0.0, stable pH
5-9, optimum action temperature 37 ° C).

【0004】また、後者には、ガングリオ系及びラクト
系のスフィンゴ糖脂質には良く作用するが、グロボ系の
スフィンゴ糖脂質には作用しにくく、単糖とセラミドと
が結合したセレブロシドは分解しない二種類の酵素(分
子量 約65000のサブユニットで構成される菌体内
酵素および分子量 約31000のサブユニットで構成
される菌体外酵素)が含まれる。
The latter acts well on ganglio-type and lacto-type glycosphingolipids, but it hardly acts on globo-type glycosphingolipids and does not decompose cerebrosides in which monosaccharides and ceramide are bound. It includes various types of enzymes (intracellular enzyme composed of subunits having a molecular weight of about 65,000 and extracellular enzyme composed of subunits having a molecular weight of about 31,000).

【0005】また、ロドコッカス属に属する微生物で、
上記とは異なる変異株が生産する、スフィンゴ糖脂質に
作用してオリゴ糖とセラミドを生成する酵素である2種
類のエンドグリコセラミダーゼが、特開平1−3096
77号公報に提示されているが、一方は、糖鎖中のグル
コースが直接セラミドと結合しているスフィンゴ糖脂質
の、グルコースとセラミドとの結合を特異的に切断して
オリゴ糖を生成するがグルコースのような単糖とセラミ
ドとが結合したセレブロシドは分解しない酵素(分子量
55,900(SDS−PAGE),至適pH 5〜
5.5,安定pH 5〜9,作用最適温度 37℃)で
あり、他方はオリゴ糖鎖中のガラクトースが直接セラミ
ドと結合しているスフィンゴ糖脂質の、ガラクトースと
セラミドとの結合を特異的に切断してオリゴ糖を生成す
るがガラクトースのような単糖とセラミドとが結合した
セレブロシドは分解しない酵素(分子量 53,700
(SDS−PAGE),至適pH 5〜5.5,安定p
H 5〜9,作用最適温度37℃)であり、いずれも単
糖とセラミドとが結合したセレブロシドには作用しない
酵素である。
Further, a microorganism belonging to the genus Rhodococcus,
Two types of endoglycoceramidase, which are enzymes produced by a mutant strain different from the above and acting on glycosphingolipids to produce oligosaccharides and ceramides, are disclosed in JP-A-1-3096.
Although it is disclosed in Japanese Patent Publication No. 77, on the other hand, the glycosphingolipid in which glucose in the sugar chain is directly bound to ceramide, specifically cleaves the bond between glucose and ceramide to produce an oligosaccharide. An enzyme that does not decompose cerebroside, which is a combination of ceramide and a monosaccharide such as glucose (molecular weight 55,900 (SDS-PAGE), optimum pH 5 to 5).
5.5, stable pH 5-9, optimum temperature of action 37 ° C), and the other specifically, the binding of galactose and ceramide of glycosphingolipid in which galactose in oligosaccharide chain is directly bound to ceramide. An enzyme (molecular weight 53,700 that cleaves to form oligosaccharides but does not degrade cerebrosides that combine monosaccharides such as galactose and ceramides
(SDS-PAGE), optimum pH 5 to 5.5, stable p
H 5-9, optimal temperature of action 37 ° C.), and both are enzymes that do not act on cerebroside in which monosaccharide and ceramide are bound.

【0006】即ち、従来知られているエンドグリコセラ
ミダーゼは、いずれも単糖とセラミドとが結合したセレ
ブロシドには作用しない酵素である。
That is, the conventionally known endoglycoceramidase is an enzyme that does not act on cerebroside in which a monosaccharide and ceramide are bound.

【0007】[0007]

【発明が解決しようとする課題】本発明の目的は、従来
知られている公知のエンドグリコセラミダーゼより基質
特異性の広い酵素、特にグロボ系のスフィンゴ糖脂質お
よび単糖とセラミドとが結合したセレブロシドにも良く
作用するエンドグリコセラミダーゼを提供することであ
る。
SUMMARY OF THE INVENTION An object of the present invention is to provide an enzyme having a wider substrate specificity than a known endoglycoceramidase known in the art, particularly a globo-type glycosphingolipid and a cerebroside in which a monosaccharide and ceramide are bound. It is to provide an endoglycoceramidase that also works well.

【0008】[0008]

【課題を解決するための手段】本発明は、下記の性質を
有する新規エンドグリコセラミダーゼを提供するもので
ある。
The present invention provides a novel endoglycoceramidase having the following properties.

【0009】作用 スフィンゴ糖脂質に作用し、糖とセラミドの結合を加水
分解してオリゴ糖または単糖とセラミドを生成する。 基質特異性 ガングリオ系、グロボ系およびラクト系のスフィンゴ糖
脂質ならびに単糖とセラミドが結合したセレブロシドに
作用して分解するが、スルファチドには実質的に作用し
ない。 至適pH 6.0〜7.0 安定pH範囲 6.0〜9.0 至適温度 40〜44℃ 熱安定性 40℃以下で安定。 阻害および活性化 Hg2+、Zn2+またはAg+によって阻害され、Ba2+
またはMg2+によって活性化される。
Action It acts on glycosphingolipids and hydrolyzes the bond between sugar and ceramide to produce oligosaccharide or monosaccharide and ceramide. Substrate specificity It acts on ganglio-type, globo-type and lacto-type glycosphingolipids and cerebrosides in which monosaccharides and ceramide are bound and decomposes, but it does not substantially act on sulfatide. Optimum pH 6.0-7.0 Stable pH range 6.0-9.0 Optimum temperature 40-44 ° C Thermal stability Stable at 40 ° C or lower. Inhibition and activation Inhibited by Hg 2+ , Zn 2+ or Ag + , Ba 2+
Or activated by Mg 2+ .

【0010】以下に本発明を詳しく説明する。本発明の
エンドグリコセラミダーゼ(以下、「本発明酵素」とい
うこともある)の製造方法は限定されない。例えば、静
岡県下のタケノコの皮に由来し、ガングリオシド(GM
1a)を唯一の炭素源とする集積培地で培養し、ガング
リオシドの消滅によって酵素生産性を判定することによ
ってスクリーニングし、分離されたグラム陽性の短桿菌
であるNo.363−2−1株を培養し、その培養物か
ら採取することができる。尚、このNo.363−2−
1株は平成4年2月25日に工業技術院微生物工業技術
研究所に寄託され、微生物受託番号、微工研菌寄第12
793号(FERM P−12793)として受託され
ている。
The present invention will be described in detail below. The method for producing the endoglycoceramidase of the present invention (hereinafter sometimes referred to as “the enzyme of the present invention”) is not limited. For example, ganglioside (GM) is derived from the skin of bamboo shoots in Shizuoka prefecture.
No. 1 which is a gram-positive bacillus isolated by culturing in an accumulation medium containing 1a) as a sole carbon source and screening by determining enzyme productivity by disappearance of ganglioside. Strain 363-2-1 can be cultured and harvested from the culture. In addition, this No. 363-2-
One strain was deposited on February 25, 1992 at the Institute for Microbial Technology, National Institute of Advanced Industrial Science and Technology, with the microorganism deposit number, and the number 12
Deposited as 793 (FERM P-12793).

【0011】本発明酵素は、該酵素を生産する微生物を
適当な培地に接種して培養し、培養後の培養物(液体培
養の時は培養液)から菌体を分離除去し(遠心分離、凝
集分離、濾過など)、次いで一般的な酵素の分離精製法
(例、「入門酵素化学」、昭和48年7月1日、(株)
南江堂発行 参照)を適用することによって必要とされ
る精製度の酵素標品として採取される。
The enzyme of the present invention is cultivated by inoculating an appropriate medium with a microorganism producing the enzyme, and separating and removing the microbial cells from the culture (culture liquid in the case of liquid culture) after the culture (centrifugation, Aggregation separation, filtration, etc., followed by general enzyme separation and purification methods (eg, "Introduction Enzyme Chemistry", July 1, 1973, Co., Ltd.)
It is collected as an enzyme preparation with the required degree of purification by applying Nankodo.

【0012】本発明酵素生産微生物の培養は、該菌が資
化可能な炭素源(牛脳アセトン粉末、精製スフィンゴ糖
脂質、グルコース、澱粉など)、窒素源(酵母エキス、
ペプトン、肉エキス、コーンスティープリカー、大豆粕
などの有機窒素源;塩酸アンモニウム、硫酸アンモニウ
ム、尿素、硝酸アンモニウムなどの無機窒素源)、無機
塩(鉄、マグネシウム、カルシウム、カリウム、ナトリ
ウムなどの硫酸塩、リン酸塩、塩酸塩など)、必要に応
じて界面活性剤などを含む培地中で好気的な培養法(振
盪培養、通気攪拌培養など)によって生育に適した温度
で数時間〜数日間培養することによって培地中に酵素を
生産させることができる。
The enzyme-producing microorganism of the present invention can be cultured by a carbon source (cattle brain acetone powder, purified sphingoglycolipid, glucose, starch, etc.) that can be assimilated by the bacterium, nitrogen source (yeast extract,
Organic nitrogen sources such as peptone, meat extract, corn steep liquor and soybean meal; inorganic nitrogen sources such as ammonium chloride, ammonium sulfate, urea and ammonium nitrate), inorganic salts (sulfates such as iron, magnesium, calcium, potassium and sodium, phosphorus) Acid salts, hydrochlorides, etc.), and optionally, a culture medium containing a surfactant by an aerobic culture method (shaking culture, aeration stirring culture, etc.) at a temperature suitable for growth for several hours to several days. Thus, the enzyme can be produced in the medium.

【0013】菌体を分離除去した液体培養後の培養液か
ら、例えば硫酸アンモニウム(硫安)、硫酸ナトリウム
等による塩析;透析;エタノール、アセトン、イソプロ
パノール、テトラヒドロフラン等の有機溶媒による沈澱
法;ヒドロキシアパタイト(水酸化リン酸カルシウム)
等による吸着クロマトグラフ法;ジエチルアミノエチル
(DEAE)基、トリエチルアミノエチル基等の交換基
を有する陰イオン交換体等によるイオン交換クロマトグ
ラフ法;アフィニティークロマトグラフ法;ゲル濾過ク
ロマトグラフ法;分子ふるい膜等による限外濾過法;電
気泳動法など公知の酵素精製法によって目的とする精製
度の酵素標品を得ることができる。
From the liquid culture after the liquid culture in which the bacterial cells have been separated and removed, for example, salting out with ammonium sulfate (ammonium sulfate), sodium sulfate, etc .; dialysis; precipitation with an organic solvent such as ethanol, acetone, isopropanol, tetrahydrofuran; hydroxyapatite ( Hydroxyl calcium phosphate)
Chromatographic method using anion exchangers having an exchange group such as diethylaminoethyl (DEAE) group and triethylaminoethyl group; affinity chromatography method; gel filtration chromatography method; molecular sieve membrane An enzyme preparation having a desired degree of purification can be obtained by a well-known enzyme purification method such as an ultrafiltration method by electrophoresis, etc .;

【0014】尚、以下の測定において酵素反応は、基本
的には以下の反応系を用いて行なった。
The enzyme reaction in the following measurements was basically carried out using the following reaction system.

【0015】〔基本反応系〕 反応液(全量200μl) 基質:20nmol GM1a(ガングリオシド;シグ
マ社製) 酵素溶液:精製酵素25μl 緩衝液:酢酸緩衝液(反応液中:50mM、pH6.
5) 界面活性剤:トリトン(Triton) X−100
(反応液中0.1%;和光純薬工業株式会社)) 反応温度:37℃ 反応時間:2時間 活性測定法:還元基定量法
[Basic reaction system] Reaction solution (total volume 200 μl) Substrate: 20 nmol GM1a (ganglioside; manufactured by Sigma) Enzyme solution: Purified enzyme 25 μl Buffer solution: Acetate buffer solution (in reaction solution: 50 mM, pH 6.
5) Surfactant: Triton X-100
(0.1% in reaction liquid; Wako Pure Chemical Industries, Ltd.) Reaction temperature: 37 ° C. Reaction time: 2 hours Activity measurement method: reducing group quantification method

【0016】本発明酵素の酵素活性は、以下の方法によ
って測定することができる。 (a)還元基定量法 適量の酵素を含む前記酵素反応液を用いて37℃で2時
間反応後、シアン化炭素溶液1mlを添加して反応を停
止させ、これに蒸留水2.8mlを加える。次に、この
溶液についてパーク・ジョンソン(Park−John
son)法(J,Biol.Chem.181,149
(1949))に従って遊離還元基を定量する。遊離還
元基は、690nmにおける吸光度を測定し、これをグ
ルコース相当量として計算する。尚、酵素活性の1単位
(ユニット(U))は、1分間に1μモルの還元基を遊
離する酵素量とした。
The enzyme activity of the enzyme of the present invention can be measured by the following method. (A) Quantitative Method for Reducing Group After using the above-mentioned enzyme reaction solution containing an appropriate amount of enzyme at 37 ° C. for 2 hours, 1 ml of carbon cyanide solution was added to stop the reaction, and 2.8 ml of distilled water was added thereto. . The solution is then Park-John.
Son) method (J, Biol. Chem. 181, 149).
(1949)) to quantify free reducing groups. For the free reducing group, the absorbance at 690 nm is measured, and this is calculated as the glucose equivalent amount. One unit of enzyme activity (unit (U)) was defined as the amount of enzyme that liberates 1 μmol of reducing groups per minute.

【0017】 (b)薄層クロマトグラフィー(TLC)法 適量の酵素を含む前記酵素反応液(但し、酵素溶液:8
5μl)を用いて37℃で48時間反応後、20μlを
シリカゲル薄層ブレートにスポットし、これをクロロフ
ォルム:メタノール:水(55:45:10,V/V)
の溶媒系で展開する。糖脂質の発色は、ガングリオシド
についてはレゾシノール塩酸試薬を用いて行ない、グロ
ボシド、ラクトシルセラミド、セレブロシドならびにス
ルファチドについては50%硫酸試薬を用いて行なう。
糖脂質の分解率は、酵素無添加の反応系における糖脂質
のスポットを対照にしてデンシトメーターで求める。
(B) Thin Layer Chromatography (TLC) Method The enzyme reaction solution containing an appropriate amount of enzyme (however, the enzyme solution: 8
After reacting with (5 μl) at 37 ° C. for 48 hours, 20 μl was spotted on a silica gel thin layer plate, which was mixed with chloroform: methanol: water (55:45:10, V / V).
It develops in the solvent system of. The color development of glycolipids is carried out using the resozinol hydrochloric acid reagent for gangliosides and the 50% sulfuric acid reagent for globoside, lactosylceramide, cerebroside and sulfatide.
The decomposition rate of glycolipid is determined by a densitometer with reference to the spot of glycolipid in the reaction system without addition of enzyme.

【0018】〔理化学的性質〕次に本発明酵素の理化学
的性質を示す。測定は実施例で得られた精製酵素を用い
て行なった。
[Physicochemical Properties] Next, the physicochemical properties of the enzyme of the present invention will be shown. The measurement was performed using the purified enzyme obtained in the example.

【0019】(1) 作 用 スフィンゴ糖脂質に作用し、糖とセラミドの結合を加水
分解してオリゴ糖または単糖とセラミドを生成する。
(1) It acts on a glycosphingolipid for production and hydrolyzes the bond between sugar and ceramide to produce oligosaccharide or monosaccharide and ceramide.

【0020】(2) 基質特異性 ガングリオ系、グロボ系、ラクト系のスフィンゴ糖脂質
および単糖とセラミドが結合したセレブロシドに作用し
て分解するが、スルファチドには実質的に作用しない。
(2) Substrate specificity It acts on ganglio-type, globo-type, lacto-type glycosphingolipids and cerebrosides in which monosaccharides and ceramide are bound and decomposes, but it does not substantially act on sulfatide.

【0021】即ち、基質として20nmolのガングリ
オ系スフィンゴ糖脂質(GM1a,GM2,GM3,G
D1a,GD1b,GD3,GT1b)、グロボ系スフ
ィンゴ糖脂質(Gb4Cer,Gb5Cer)、ラクト
系スフィンゴ糖脂質(ラクトシルセラミド)のスフィン
ゴ糖脂質および単糖とセラミドが結合したセレブロシド
(ガラクトセレブロシド、グルコセレブロシド)ならび
にスルファチドをそれぞれ含む反応液を用いて前記〔基
本反応系〕に準じて(但し、酵素溶液,85μl)反応
させ、反応時間2時間のものを還元基定量法により、反
応時間48時間のものを薄層クロマトグラフィー(TL
C)法で酵素活性(分解速度と加水分解率)を測定した
ところ、表1に示すようにガングリオ系、グロボ系,ラ
クト系のスフィンゴ糖脂質および単糖とセラミドが結合
したセレブロシド(ガラクトセレブロシド、グルコセレ
ブロシド)に作用して48時間後には100%分解する
が、スルファチドには実質的に作用しないことが判明し
た。
That is, 20 nmol of ganglio-based glycosphingolipid (GM1a, GM2, GM3, G as a substrate)
D1a, GD1b, GD3, GT1b), globo-based glycosphingolipids (Gb4Cer, Gb5Cer), lacto-sphingolipids (lactosylceramide) glycosphingolipids, and cerebrosides (galactocerebrosides, glucocerebrosides) in which monosaccharides and ceramides are linked. And a reaction solution containing sulfatide, respectively, according to the above [basic reaction system] (however, an enzyme solution, 85 μl) is reacted, and a reaction time of 2 hours is measured by a reducing group quantification method and a reaction time of 48 hours is used. Thin layer chromatography (TL
When the enzyme activity (decomposition rate and hydrolysis rate) was measured by the C) method, as shown in Table 1, ganglio-, globo-, and lacto-sphingoglycolipids and cerebrosides (galactocerebroside, monosaccharides and ceramides bound to ceramides, It was found that after 48 hours, 100% was decomposed after acting on glucocerebrosid, but it did not substantially act on sulfatide.

【0022】また、2時間反応では48時間反応と同様
にスルファチド以外のスフィンゴ糖脂質に作用したが、
その種類によって加水分解の速度に差があり、GM1a
が最も速く、次いでGM2が速かった。
Further, in the 2 hour reaction, it acted on glycosphingolipids other than sulfatide as in the 48 hour reaction,
There is a difference in the hydrolysis rate depending on the type, and GM1a
Was the fastest, followed by GM2.

【0023】[0023]

【表1】 [Table 1]

【0024】このように、本発明酵素は従来のエンドグ
リコセラミダーゼに比べて基質特異性が広く、殊に、従
来のエンドグリコセラミダーゼがグルコース、ガラクト
ースなどの単糖とセラミドとが結合したセレブロシドに
は作用しないのに対して、セレブロシドに作用して分解
するものであり、この点において従来の酵素と区別され
る。
As described above, the enzyme of the present invention has a wider substrate specificity than the conventional endoglycoceramidase, and in particular, the conventional endoglycoceramidase is not particularly effective for cerebroside in which monosaccharides such as glucose and galactose and ceramide are bound. It does not act, but acts on cerebroside and decomposes, and in this respect, it is distinguished from conventional enzymes.

【0025】(3) 至適pH 本発明酵素について、緩衝液として、50mM酢酸緩衝
液を用いてpH 4.5〜7.5の各pHで反応を行っ
たほかは前記〔基本反応系〕に従って酵素反応を行ない
酵素活性を測定したしたところ、図1に示すように本発
明酵素はpH6.0〜7.0において好適に作用し、最
も好適に作用するのはpH 6.5付近であった。
(3) Optimum pH For the enzyme of the present invention, 50 mM acetate buffer was used as a buffer solution, and the reaction was carried out at each pH of 4.5 to 7.5 according to the above [basic reaction system]. When the enzyme reaction was carried out and the enzyme activity was measured, as shown in FIG. 1, the enzyme of the present invention suitably acted at pH 6.0 to 7.0, and most suitably acted at around pH 6.5. .

【0026】(4) 安定pH範囲 本発明酵素溶液に所定のpHになるように各pHに調整
した200mMの緩衝液(酢酸緩衝液、トリス−塩酸緩
衝液、炭酸ナトリウム−炭酸水素ナトリウム緩衝液)を
等量加え、4℃で27時間放置した後、0.1%のトリ
トン X−100を含む50mM酢酸緩衝液(pH
6.5)に対して透析し、これを前記〔基本反応系〕に
従って酵素反応を行ない、酵素活性を測定した。その結
果、図2に示すように本発明酵素はpH 6.0〜9.
0で安定であった。
(4) Stable pH range 200 mM buffer solution (acetic acid buffer solution, Tris-hydrochloric acid buffer solution, sodium carbonate-sodium hydrogen carbonate buffer solution) adjusted to each pH so that the enzyme solution of the present invention has a predetermined pH Was added for 27 hours at 4 ° C., and then 50 mM acetate buffer (pH: 0.1% Triton X-100) was added.
It was dialyzed against 6.5), and an enzyme reaction was carried out according to the above [basic reaction system] to measure the enzyme activity. As a result, as shown in FIG. 2, the enzyme of the present invention had a pH of 6.0 to 9.
It was stable at 0.

【0027】(5) 至適温度 本発明酵素について、反応温度を30〜47℃の所定温
度としたほかは前記〔基本反応系〕に従って酵素反応を
行ない酵素活性を測定したしたところ、図3に示すよう
に本発明酵素は40〜44℃において好適に作用し、最
も好適に作用するのは42℃付近であった。
(5) Optimum temperature For the enzyme of the present invention, the enzyme reaction was carried out according to the above [basic reaction system] except that the reaction temperature was set to a predetermined temperature of 30 to 47 ° C., and the enzyme activity was measured. As shown, the enzyme of the present invention suitably acted at 40 to 44 ° C, and most suitably acted at around 42 ° C.

【0028】(6) 熱安定性 本発明酵素溶液に50mMの酢酸緩衝液(pH 6.
5)を加え、0〜60℃の所定温度で15分間静置した
後、前記〔基本反応系〕に従って酵素反応を行ない残存
活性を調べたところ、図4に示すように、40℃以下の
温度での処理では完全に活性を保持し、55℃の処理で
無処理の約50%の残存活性があることが判明した。
(6) Thermostability A 50 mM acetate buffer solution (pH 6.
5) was added, and the mixture was allowed to stand at a predetermined temperature of 0 to 60 ° C for 15 minutes, and then an enzymatic reaction was carried out according to the above [basic reaction system] to examine the residual activity. It was found that the treatment with the above treatment completely retained the activity, and the treatment at 55 ° C. had a residual activity of about 50% of the untreated treatment.

【0029】(7) 阻害および活性化 本発明酵素について、無機イオンおよび酵素阻害剤(無
機イオンの場合にはその塩として)を反応液に添加し、
前記〔基本反応系〕に従って酵素反応を行ない酵素阻害
剤の影響を調べた。調べた結果を表2に示す。
(7) Inhibition and Activation Regarding the enzyme of the present invention, an inorganic ion and an enzyme inhibitor (in the case of inorganic ion, as a salt thereof) are added to the reaction solution,
The enzyme reaction was carried out according to the above [basic reaction system] to examine the influence of the enzyme inhibitor. The results of the examination are shown in Table 2.

【0030】[0030]

【表2】 [Table 2]

【0031】表2から本発明酵素の反応はHg2+、Zn
2+またはAg+によって阻害され、Ba2+またはMg2+
によって活性化されること、また、PCMB(P−クロ
ロメルクリ安息香酸)およびEDTA(エチレンジアミ
ン四酢酸)の添加は酵素活性に殆ど影響を与えないこと
が判明した。
From Table 2, the reaction of the enzyme of the present invention is Hg 2+ , Zn
Inhibited by 2+ or Ag + , Ba 2+ or Mg 2+
It was found that the enzyme activity was activated by addition of PCMB (P-chloromercuribenzoic acid) and EDTA (ethylenediaminetetraacetic acid).

【0032】(8) 界面活性剤の影響 前記〔基本反応系〕からトリトンX−100を除いた反
応液に下記表3に示す各種界面活性剤を0.2%となる
ように添加し、前記〔基本反応系〕に従って反応を行な
い酵素活性を測定した。結果を表3に示す。
(8) Effect of Surfactant Various surfactants shown in Table 3 below were added to the reaction solution obtained by removing Triton X-100 from the above [basic reaction system] so as to be 0.2%. The reaction was performed according to the [basic reaction system], and the enzyme activity was measured. The results are shown in Table 3.

【0033】尚、表3中、Tween(トゥイーン)2
0は半井化学薬品株式会社の製品であり、Brij(ブ
リジ)は花王アトラス株式会社の製品である。また、S
DSはラウリル硫酸ナトリウムである。
In Table 3, Tween 2
0 is a product of Hanai Chemical Co., Ltd., and Brij is a product of Kao Atlas Co., Ltd. Also, S
DS is sodium lauryl sulfate.

【0034】[0034]

【表3】 [Table 3]

【0035】表3から本発明酵素の反応が0.2%の各
種界面活性剤の添加により阻害されることが判明した。
From Table 3, it was found that the reaction of the enzyme of the present invention was inhibited by the addition of 0.2% of various surfactants.

【0036】更に、界面活性剤の内、トリトン X−1
00について濃度を0〜1.0%の各濃度に調整して前
記各種界面活性剤と同様に酵素活性を測定したところ、
図5に示すようにトリトン X−100を0.1%添加
した場合には僅かに酵素活性が増加するが、0.2%以
上になると活性増加は見られず、逆に阻害的に作用する
ことが判明した。
Further, among the surfactants, Triton X-1
For 00, the concentration was adjusted to each concentration of 0 to 1.0% and the enzyme activity was measured in the same manner as the above-mentioned various surfactants.
As shown in FIG. 5, when 0.1% of Triton X-100 was added, the enzyme activity slightly increased, but when it was 0.2% or more, the activity did not increase, and on the contrary, it acts as an inhibitor. It has been found.

【0037】尚、従来のエンドグリコセラミダーゼは界
面活性剤(タウロデオキシコール酸ナトリウムなど)の
添加によって酵素活性が顕著に増大することが知られて
いるが(特開昭62−122587号および特開平1−
309677号公報参照)、本発明酵素は比較的高濃度
の界面活性剤の添加によって活性が阻害される点で従来
の酵素と区別される。
It is known that the enzyme activity of conventional endoglycoceramidase is remarkably increased by the addition of a surfactant (sodium taurodeoxycholate, etc.) (Japanese Patent Laid-Open No. 62-122587 and Japanese Patent Laid-Open No. 122587/1987). 1-
309677), the enzyme of the present invention is distinguished from conventional enzymes in that the activity is inhibited by the addition of a relatively high concentration of a surfactant.

【0038】(9) 分子量 本発明酵素について、ゲルロ過法(スーパーロース(S
uperose)12カラム(ファルマシア社製)使用
の高速液体クロマトグラフィー;流速0.4ml/分)
により分子量を調べたところ、約95,000であり、
ポリアクリルアミドゲル電気泳動法(レディーゲル(バ
イオ・ラッド社製);200V定電流)で調べたとこ
ろ、約90,000であった。
(9) Molecular weight Regarding the enzyme of the present invention, the gel filtration method (superrose (S
upperose) 12 column (Pharmacia); high performance liquid chromatography; flow rate 0.4 ml / min)
When the molecular weight was examined by, it was about 95,000,
It was about 90,000 when examined by polyacrylamide gel electrophoresis (Ready gel (manufactured by Bio-Rad); 200 V constant current).

【0039】(10) 等電点 本発明酵素について、等電点(pI)を等電点電気泳動
法(アンホライト等電点電気泳動法カラム(LKB社
製);400V定電流、72時間泳動)によって求めた
ところ、pIは4.05であった。
(10) Isoelectric point With respect to the enzyme of the present invention, the isoelectric point (pI) is determined by isoelectric focusing (Ampholitic isoelectric focusing column (LKB); 400 V constant current, 72 hours). The pI was 4.05 as determined by.

【0040】[0040]

【実施例】次に実施例により本発明を更に詳しく説明す
るが、この実施例は本発明の一例を示すものであり、こ
れに限定されるものではない。
EXAMPLES Next, the present invention will be described in more detail by way of examples, which are examples of the present invention and are not limited thereto.

【0041】牛脳アセトン粉末(シグマ社製)1.0
%,ペプトン0.5%,酵母エキス0.1%,塩化ナト
リウム0.2%,pH 7.0からなる生産培地を5l
の三角フラスコに1000ml分注し、オートクレイブ
した。No.363−2−1株を接種した後、ロータリ
ーシェイカーを用いて、30℃で4日間振盪培養した。
Beef brain acetone powder (manufactured by Sigma) 1.0
%, Peptone 0.5%, yeast extract 0.1%, sodium chloride 0.2%, pH 7.0 5 liters of production medium
1000 ml was dispensed into the Erlenmeyer flask and autoclaved. No. After inoculating the 363-2-1 strain, the cells were shake-cultured at 30 ° C. for 4 days using a rotary shaker.

【0042】遠心分離(9000rpm,10分)した
培養液の上清(培養上清;890ml)を冷却して、8
0%飽和になるまで硫安を加え、4℃で一晩放置した
後、沈殿物をロ紙を用いてロ過し、ロ紙上の沈殿物を適
量の緩衝液A(0.1%のトリトンX−100を含む5
0mM酢酸緩衝液、pH 6.5)に溶解し、緩衝液A
に対して、4℃で二晩透析した。
The supernatant (culture supernatant; 890 ml) of the culture solution centrifuged (9000 rpm, 10 minutes) was cooled to 8
Ammonium sulfate was added to 0% saturation, and the mixture was allowed to stand at 4 ° C. overnight. The precipitate was filtered using a paper filter, and the precipitate on the paper was buffered with an appropriate amount of buffer A (0.1% Triton X. 5 including -100
Dissolve in 0 mM acetate buffer, pH 6.5) to obtain buffer A
Against it, it was dialyzed at 4 ° C. for two nights.

【0043】次に、前記透析液(45ml)を限外ロ過
器(東洋ロ紙社製、UHP−25)で10mlまで濃縮
し、その全量をセファデックス(Sephadex)G
−100(ファルマシァ社製)のカラム(1.8×60
cm)に充填し、流速10ml/時間で酵素を溶出させ
た。
Next, the dialysate (45 ml) was concentrated to 10 ml with an ultrafiltration device (UHP-25, manufactured by Toyo Roshi Co., Ltd.), and the whole amount was separated by Sephadex G.
-100 (Pharmacia) column (1.8 x 60)
cm) and the enzyme was eluted at a flow rate of 10 ml / hour.

【0044】溶出させた活性画分(84ml)を、DE
AE−セファロース(Sepharose)CL−6B
(ファルマシァ社製)カラム(1.8×10cm)に吸
着させ、流速10ml/時間で酵素を0〜0.5M塩化
ナトリウムの直線的濃度勾配で溶出させた。
The eluted active fraction (84 ml) was added to DE
AE-Sepharose CL-6B
It was adsorbed on a column (manufactured by Pharmacia) (1.8 × 10 cm), and the enzyme was eluted with a linear concentration gradient of 0 to 0.5 M sodium chloride at a flow rate of 10 ml / hour.

【0045】更に、溶出させた活性画分(41ml)を
限外ロ過器で12mlまで濃縮した後、その全量を11
0mlのアンホライト等電点電気泳動カラム(LKB社
製)に充填し、2℃、定電流(400V)で72時間泳
動させた。泳動後、2mlずつを分画し、pHを測定
し、各画分を前記緩衝液Aを用いて48時間透析した
後、酵素活性を測定した。
Further, the eluted active fraction (41 ml) was concentrated to 12 ml with an ultrafilter, and then the total amount was 11
It was packed in 0 ml of an ampholite isoelectric focusing column (manufactured by LKB) and electrophoresed at 2 ° C. and constant current (400 V) for 72 hours. After the electrophoresis, 2 ml of each fraction was fractionated, the pH was measured, and each fraction was dialyzed against the buffer solution A for 48 hours, and then the enzyme activity was measured.

【0046】そして、活性画分(8ml)を限外ロ過器
で2mlまで濃縮して精製酵素溶液を得た。
Then, the active fraction (8 ml) was concentrated to 2 ml with an ultrafilter to obtain a purified enzyme solution.

【0047】得られた精製酵素についての各精製段階毎
に酵素活性、蛋白量、収率などを表4に示す。
Table 4 shows the enzyme activity, the amount of protein, the yield, etc. for each purification step of the obtained purified enzyme.

【0048】[0048]

【表4】 [Table 4]

【0049】[0049]

【発明の効果】本発明によると、従来知られている公知
のエンドグリコセラミダーゼに比べて基質特異性が広
く、殊に、従来のエンドグリコセラミダーゼがグルコー
ス、ガラクトースなどの単糖とセラミドとが結合したセ
レブロシドには作用しないのに対して、セレブロシドに
作用して分解するものであり、この点において従来の酵
素と区別され、糖脂質の糖鎖の構造や機能の解析などの
研究に有用な試薬などへの活用が期待される。
EFFECTS OF THE INVENTION According to the present invention, the substrate specificity is wider than that of the conventionally known publicly known endoglycoceramidase, and in particular, the conventional endoglycoceramidase binds monosaccharides such as glucose and galactose with ceramide. It does not act on the cerebrosides, but it acts on the cerebrosides to decompose it, and in this respect it is distinguished from conventional enzymes and is a reagent useful for research such as analysis of the structure and function of sugar chains of glycolipids. It is expected to be utilized for such purposes.

【0050】また、従来のエンドグリコセラミダーゼと
異なり比較的高濃度の界面活性剤の添加によって活性が
阻害されるなど従来の酵素と区別される新規な性質を有
するものである。
Further, unlike the conventional endoglycoceramidase, it has a novel property that is distinguished from the conventional enzyme such that the activity is inhibited by the addition of a relatively high concentration of surfactant.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明酵素の至適pHを示すpH−酵素活性曲
線である。
FIG. 1 is a pH-enzyme activity curve showing the optimum pH of the enzyme of the present invention.

【図2】本発明酵素の安定pHを示すpH−酵素活性曲
線である。
FIG. 2 is a pH-enzyme activity curve showing the stable pH of the enzyme of the present invention.

【図3】本発明酵素の至適温度を示す温度−酵素活性曲
線である。
FIG. 3 is a temperature-enzyme activity curve showing the optimum temperature of the enzyme of the present invention.

【図4】本発明酵素の安定温度範囲を示す温度−残存活
性曲線である。
FIG. 4 is a temperature-residual activity curve showing a stable temperature range of the enzyme of the present invention.

【図5】本発明酵素へのトリトン X−100の影響を
示す添加濃度−酵素活性曲線である。
FIG. 5 is an addition concentration-enzyme activity curve showing the influence of Triton X-100 on the enzyme of the present invention.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 下記の理化学的性質を有する新規エンド
グリコセラミダーゼ; 作用 スフィンゴ糖脂質に作用し、糖とセラミドの結合を加水
分解してオリゴ糖または単糖とセラミドを生成する。 基質特異性 ガングリオ系、グロボ系およびラクト系のスフィンゴ糖
脂質ならびに単糖とセラミドが結合したセレブロシドに
作用して分解するが、スルファチドには実質的に作用し
ない。 至適pH 6.0〜7.0 安定pH範囲 6.0〜9.0 至適温度 40〜44℃ 熱安定性 40℃以下で安定。 阻害および活性化 Hg2+、Zn2+またはAg+によって阻害され、Ba2+
またはMg2+によって活性化される。
1. A novel endoglycoceramidase having the following physicochemical properties: Action It acts on glycosphingolipids and hydrolyzes the bond between sugar and ceramide to produce oligosaccharide or monosaccharide and ceramide. Substrate specificity It acts on ganglio-type, globo-type and lacto-type glycosphingolipids and cerebrosides in which monosaccharides and ceramide are bound and decomposes, but it does not substantially act on sulfatide. Optimum pH 6.0-7.0 Stable pH range 6.0-9.0 Optimum temperature 40-44 ° C Thermal stability Stable at 40 ° C or lower. Inhibition and activation Inhibited by Hg 2+ , Zn 2+ or Ag + , Ba 2+
Or activated by Mg 2+ .
JP08276892A 1992-03-04 1992-03-04 Novel endoglycoceramidase Expired - Fee Related JP3191170B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP08276892A JP3191170B2 (en) 1992-03-04 1992-03-04 Novel endoglycoceramidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08276892A JP3191170B2 (en) 1992-03-04 1992-03-04 Novel endoglycoceramidase

Publications (2)

Publication Number Publication Date
JPH067161A true JPH067161A (en) 1994-01-18
JP3191170B2 JP3191170B2 (en) 2001-07-23

Family

ID=13783618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP08276892A Expired - Fee Related JP3191170B2 (en) 1992-03-04 1992-03-04 Novel endoglycoceramidase

Country Status (1)

Country Link
JP (1) JP3191170B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912152A (en) * 1995-02-28 1999-06-15 Yakurigaku Chuo Kenkyusho Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide
EP0751222A3 (en) * 1995-06-29 1999-11-03 Takara Shuzo Co. Ltd. Gene encoding endoglycoceramidase
DE4431847C5 (en) * 1994-09-07 2011-01-27 Atotech Deutschland Gmbh Substrate with bondable coating
KR20130112052A (en) 2010-11-26 2013-10-11 제이에프이 스틸 가부시키가이샤 Al-zn-based hot-dip plated steel sheet and manufacturing method thereof
JP2017195855A (en) * 2016-04-28 2017-11-02 株式会社ダイセル Method for producing ceramide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4431847C5 (en) * 1994-09-07 2011-01-27 Atotech Deutschland Gmbh Substrate with bondable coating
US5912152A (en) * 1995-02-28 1999-06-15 Yakurigaku Chuo Kenkyusho Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide
EP0751222A3 (en) * 1995-06-29 1999-11-03 Takara Shuzo Co. Ltd. Gene encoding endoglycoceramidase
KR20130112052A (en) 2010-11-26 2013-10-11 제이에프이 스틸 가부시키가이샤 Al-zn-based hot-dip plated steel sheet and manufacturing method thereof
JP2017195855A (en) * 2016-04-28 2017-11-02 株式会社ダイセル Method for producing ceramide

Also Published As

Publication number Publication date
JP3191170B2 (en) 2001-07-23

Similar Documents

Publication Publication Date Title
JPH0751064B2 (en) Novel hyaluronidase SD-678 and method for producing the same
JP3191170B2 (en) Novel endoglycoceramidase
JPH0236230B2 (en)
JPS6030679A (en) Preparation of s-adenosyl-l-homocysteine hydrolase
Takahashi et al. Purification and some properties of chitinase produced by Vibrio sp.
US5756314A (en) Method for preparation of monosialoganglioside GM1
JP3647873B2 (en) Novel deaminoneuraminidase and production method thereof
EP0274533A1 (en) Process for preparing neuraminidase
JP3003009B2 (en) Mannose isomerase and method for producing mannose using the same
JPH1045792A (en) Production of lysosphingolipid
JP2970932B2 (en) Novel heat-stable β-galactosyltransferase, its production method and its use
JPH04200386A (en) Beta-fructofuranosidase and production thereof
JP3100012B2 (en) Novel neuraminidase, method for producing the same, and method for producing sialic acid binding compound using the same
JP2731100B2 (en) Dextran sucrase-producing novel microorganism and method for producing dextran sucrase using the novel microorganism
JPH06237782A (en) Method for separating and obtaining mannose
JPH0229311B2 (en)
JP3617688B2 (en) β-N-acetylglucosaminidase
JP3494686B2 (en) Method for producing isomaltosyl fructoside
JPH02234677A (en) D-aminoacylase acting on acidic d-amino acid and production thereof
JPH072116B2 (en) Method for producing difructose and dianhydride III
JPH04117281A (en) Production of betaine aldehyde dehydrogenase
JPH0349682A (en) Novel alpha-l-fucosidase and its preparation
JPS6098982A (en) Preparation of enzyme for measuring polyamine
JPS6228678B2 (en)
JP3812954B2 (en) Method for producing isomaltosyl fructoside

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000926

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080525

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090525

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090525

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees